159 related articles for article (PubMed ID: 9375883)
1. Association of factor V Leiden with Behçet's disease.
Mammo L; Al-Dalaan A; Bahabri SS; Saour JN
J Rheumatol; 1997 Nov; 24(11):2196-8. PubMed ID: 9375883
[TBL] [Abstract][Full Text] [Related]
2. Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis.
Silingardi M; Salvarani C; Boiardi L; Accardo P; Iorio A; Olivieri I; Cantini F; Salvi F; La Corte R; Triolo G; Ciccia F; Ghirarduzzi A; Filippini D; Paolazzi G; Iori I
Arthritis Rheum; 2004 Apr; 51(2):177-83. PubMed ID: 15077257
[TBL] [Abstract][Full Text] [Related]
3. Factor V Leiden mutation in patients with Behçet's disease.
Oner AF; Gürgey A; Gürler A; Mesci L
J Rheumatol; 1998 Mar; 25(3):496-8. PubMed ID: 9517770
[TBL] [Abstract][Full Text] [Related]
4. Effects of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothombin gene G20210A mutations on deep venous thrombogenesis in Behçet's disease.
Toydemir PB; Elhan AH; Tükün A; Toydemir R; Gürler A; Tüzüner A; Bökesoy I
J Rheumatol; 2000 Dec; 27(12):2849-54. PubMed ID: 11128675
[TBL] [Abstract][Full Text] [Related]
5. Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies.
Chopra N; Koren S; Greer WL; Fortin PR; Rauch J; Fortin I; Senécal JL; Docherty P; Hanly JG
J Rheumatol; 2002 Aug; 29(8):1683-8. PubMed ID: 12180730
[TBL] [Abstract][Full Text] [Related]
6. Thrombophilic risk factors and homocysteine levels in Behçet's disease in eastern Spain and their association with thrombotic events.
Ricart JM; Vayá A; Todolí J; Calvo J; Villa P; Estellés A; España F; Santaolaria M; Corella D; Aznar J
Thromb Haemost; 2006 Apr; 95(4):618-24. PubMed ID: 16601831
[TBL] [Abstract][Full Text] [Related]
7. [Cerebral venous thrombosis and factor V Leiden mutation].
Meng Q; Pu C
Zhonghua Yi Xue Za Zhi; 2002 Jan; 82(1):47-9. PubMed ID: 11953127
[TBL] [Abstract][Full Text] [Related]
8. Factor V Leiden mutation investigated by amplification created restriction enzyme site (ACRES) in PNH patients with and without thrombosis.
Nafa K; Bessler M; Mason P; Vulliamy T; Hillmen P; Castro-Malaspina H; Luzzatto L
Haematologica; 1996; 81(6):540-2. PubMed ID: 9009443
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and association of the factor V Leiden and prothrombin G20210A in healthy subjects and patients with venous thromboembolism.
Coen D; Zadro R; Honović L; Banfić L; Stavljenić Rukavina A
Croat Med J; 2001 Aug; 42(4):488-92. PubMed ID: 11471205
[TBL] [Abstract][Full Text] [Related]
10. Factor V Leiden and thrombotic complications in heparin-induced thrombocytopenia.
Lee DH; Warkentin TE; Denomme GA; Lagrotteria DD; Kelton JG
Thromb Haemost; 1998 Jan; 79(1):50-3. PubMed ID: 9459322
[TBL] [Abstract][Full Text] [Related]
11. Risk of thrombosis in patients with antiphospholipid antibodies and factor V Leiden mutation.
Pablos JL; Caliz RA; Carreira PE; Atsumi T; Serrano L; Amengual O; Santiago B; Khamashta MA; Hughes GR; Gomez-Reino JJ
J Rheumatol; 1999 Mar; 26(3):588-90. PubMed ID: 10090167
[TBL] [Abstract][Full Text] [Related]
12. [Effects of factor V Leiden mutations on prognosis in patients with acute myocardial infarction].
Baykan M; Celik S; Uçar F; Kaplan S; Ovali E; Erdöl C
Anadolu Kardiyol Derg; 2001 Dec; 1(4):242-5; AXIV. PubMed ID: 12101832
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of factor V leiden mutation in patients with thrombosis in Tunisia.
Ajem A; Slama A; Slama FB; Mehjoub T
East Mediterr Health J; 2009; 15(6):1483-8. PubMed ID: 20218141
[TBL] [Abstract][Full Text] [Related]
14. [Leiden, G20210A mutations in prothrombin gene and antiphospholipid antibodies in systemic lupus erythematosus and antiphospholipid syndrome].
Reshetniak TM; Patrushev LI; Stukacheva EA; Miroshnikov AI; Tikhonova TL; Nasonov EL; Alekberova ZS
Ter Arkh; 2000; 72(5):34-8. PubMed ID: 11109617
[TBL] [Abstract][Full Text] [Related]
15. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of factor V Leiden as a risk factor for venous thromboembolism in the population of North-Western Greece.
Ioannou HV; Mitsis M; Eleftheriou A; Matsagas M; Nousias V; Rigopoulos C; Vartholomatos G; Kappas AM
Int Angiol; 2000 Dec; 19(4):314-8. PubMed ID: 11305729
[TBL] [Abstract][Full Text] [Related]
17. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
[TBL] [Abstract][Full Text] [Related]
18. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
Miñano A; Ordóñez A; España F; González-Porras JR; Lecumberri R; Fontcuberta J; Llamas P; Marín F; Estellés A; Alberca I; Vicente V; Corral J
Haematologica; 2008 May; 93(5):729-34. PubMed ID: 18387978
[TBL] [Abstract][Full Text] [Related]
19. Thrombophilic factors are not the leading cause of thrombosis in Behçet's disease.
Leiba M; Seligsohn U; Sidi Y; Harats D; Sela BA; Griffin JH; Livneh A; Rosenberg N; Gelernter I; Gur H; Ehrenfeld M
Ann Rheum Dis; 2004 Nov; 63(11):1445-9. PubMed ID: 15479893
[TBL] [Abstract][Full Text] [Related]
20. Thrombophilic factors and their relation to thromboembolic and other clinical manifestations in Behçet's disease.
Mader R; Ziv M; Adawi M; Mader R; Lavi I
J Rheumatol; 1999 Nov; 26(11):2404-8. PubMed ID: 10555901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]